交互式虚拟肾脏科医生用于晚期CKD患者肾移植宣教
本研究开发了基于视频的交互式虚拟移植肾脏科医生平台,为eGFR<25 mL/min/1.73 m2的晚期CKD患者提供个性化肾移植教育。单臂开放标签试验显示,干预后患者与医生讨论肾移植的意愿显著提高(平均增加0.30,P<0.001)。
要点
- 虚拟肾脏科医生可随时通过智能手机访问,患者自选医生特征并自定学习主题。
- 干预后患者与临床医生讨论肾移植的意愿显著增加(平均增加0.30,P<0.001)。
- 女性及黑人患者分别偏好选择性别一致(P<0.001)或种族一致(P<0.001)的虚拟医生。
核心结论
- 虚拟临床医生为肾移植等复杂治疗的宣教和患者参与提供了有前景的途径。
- 该可定制方法值得在随机试验中进一步验证。
研究设计与样本
- 单臂、开放标签试验,主要结局在干预前后评估。
- 纳入年龄≥18且<75岁、eGFR<25 mL/min/1.73 m2的成人患者。
主要发现
- 参与者中位年龄66岁,女性占59%,黑人占50%。
- 女性参与者偏好选择性别一致的虚拟肾脏科医生(P<0.001),黑人参与者偏好选择种族一致的虚拟肾脏科医生(P<0.001)。
- 参与者中位用时12.6分钟,中位回顾11个主题。
- 与临床医生讨论肾移植的意愿在虚拟会面后显著增加(平均增加0.30,P<0.001)。
临床怎么用
- 虚拟肾脏科医生平台可作为晚期CKD患者肾移植宣教的补充工具。
- 可根据患者性别或种族偏好选择虚拟医生特征以提高参与度。
局限性
- 结局的临床意义尚不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Despite advantages in survival and quality of life with kidney transplantation (KT) compared with other treatments for kidney failure requiring dialysis, many patients do not receive sufficient information about KT or have concerns about it. New artificial intelligence capabilities enable the creation of virtual agents to supplement human efforts to engage patients in regard to treatment options. STUDY DESIGN: Single-arm, open-label trial with the primary outcome assessed before and after intervention. SETTING & PARTICIPANTS: Adults (age ≥18 and <75 years) with estimated glomerular filtration rate <25 mL/min/1.73 m2 in a large health system. INTERVENTIONS: Our group developed the "virtual transplant nephrologist," an interactive, video-based platform to provide personalized education about KT. Meetings could occur at any time from a smartphone with a weblink. Participants first selected the demographic profile of their virtual nephrologist. Participants then self-tailored the encounter, choosing among 11 topics, pausing, changing the topic, and requesting more information. OUTCOME: The primary outcome was the difference in participants' intentions to speak to their doctor about KT before versus after the intervention, assessed on a 5-point Likert-like scale. RESULTS: Participants had a median age of 66 years; 59% were female, and 50% were Black. Female and Black participants exhibited preferences to select a gender- (P < 0.001) or race- (P < 0.001) concordant virtual nephrologist, respectively. Participants spent a median 12.6 minutes reviewing a median of 11 topics in the encounter. The primary outcome of intention to speak to a clinician about KT increased significantly after the virtual encounter (mean increase, 0.30; P < 0.001). LIMITATIONS: The clinical significance of the outcome is uncertain. CONCLUSIONS: Virtual clinicians offer a promising path to education and engagement in regard to complex treatments such as KT. This customizable approach to providing high-quality information about KT using a virtual clinician warrants more definitive testing in a randomized trial. FUNDING: Grant from a nonprofit entity (Leonard Davis Institute at the University of Pennsylvania, supported by a gift from Monogram Health). TRIAL REGISTRATION: Registered at Clinicaltrials.gov with study number NCT06841016. PLAIN-LANGUAGE SUMMARY: Many patients with kidney failure requiring dialysis never learn about kidney transplantation or pursue this treatment. This study used artificial intelligence and high-quality information about kidney transplantation to create the "virtual nephrologist," a series of videos that simulate a meeting with a doctor who teaches about transplantation. The study team then tested whether a meeting with the virtual nephrologist increased patients' intentions to speak to their physicians about transplantation. The virtual nephrologist could be accessed on a smartphone or computer at any time and used simple language. Patients chose from 4 nephrologists with different backgrounds and went through topics including the waiting list and finding a transplant center. Participants reported that they were more likely to talk to their doctors about transplantation after using the virtual nephrologist, highlighting a need for more research on applying new technologies like this virtual nephrologist to engage patients about important health topics.
引用
- Reese PP, Tamboli D, Potluri V, et al. An Interactive Virtual Nephrologist to Engage Patients With Advanced CKD About Transplantation. Am J Kidney Dis. 2026. PMID: 42448023. doi:10.1053/j.ajkd.2026.04.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。